美敦力2025财年营收达335亿美元,同比增长4.9%,净利润约46.6亿美元,每股收益3.61美元,同比增长31%。神经科学板块收入近100亿美元,同比增长5%,主要由脊髓刺激器和脑深部刺激器推动。糖尿病业务(营收27.6亿美元,增长11.5%)将在18个月内拆分并进行IPO,新公司CEO为Que Dallara。拆分后,美敦力将更专注于高利润增长领域,如脉冲场消融等创新产品。此次拆分延续了...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.